{
  "pmid": "15173278",
  "uid": "15173278",
  "title": "Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Jankowski",
      "fore_name": "Janusz",
      "initials": "J",
      "name": "Janusz Jankowski",
      "affiliations": []
    },
    {
      "last_name": "Moayyedi",
      "fore_name": "Paul",
      "initials": "P",
      "name": "Paul Moayyedi",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Journal of the National Cancer Institute",
    "iso_abbreviation": "J Natl Cancer Inst",
    "issn": "1460-2105",
    "issn_type": "Electronic",
    "volume": "96",
    "issue": "11",
    "pub_year": "2004",
    "pub_month": "Jun",
    "pub_day": "02"
  },
  "start_page": "885",
  "end_page": "887",
  "pages": "885-7; author reply 887",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Adenocarcinoma",
    "Adult",
    "Aged",
    "Anti-Ulcer Agents",
    "Aspirin",
    "Barrett Esophagus",
    "Cost-Benefit Analysis",
    "Drug Administration Schedule",
    "Drug Costs",
    "Drug Therapy, Combination",
    "Esophageal Neoplasms",
    "Evidence-Based Medicine",
    "Humans",
    "Male",
    "Middle Aged",
    "Omeprazole",
    "Prospective Studies",
    "Randomized Controlled Trials as Topic",
    "Survival Rate",
    "United Kingdom"
  ],
  "article_ids": {
    "pubmed": "15173278",
    "doi": "10.1093/jnci/djh171"
  },
  "doi": "10.1093/jnci/djh171",
  "dates": {
    "completed": "2004-06-15",
    "revised": "2025-05-29"
  },
  "chemicals": [
    "Anti-Ulcer Agents",
    "Omeprazole",
    "Aspirin"
  ],
  "grants": [
    {
      "grant_id": "4584",
      "agency": "Cancer Research UK",
      "country": "United Kingdom"
    }
  ],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:44:52.740942",
    "pmid": "15173278"
  }
}